ARCHIVES

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

This article is from The Cancer Letter archive.

Vol. 05 No. 02 | January 12, 1979

Download PDF Visit The Full Archive

Related Articles

NCI Invites “Extraordinary Opportunities” For Research. Groups Planning Promotion Of Cancer Clinical Trials.

May 4, 2001

Sen. Arlen Specter Remembered as Champion Of Federal Biomedical Resesarch Funding

October 19, 2012

Duke Deans Acknowledge Withholding Key Document From Outside Reviewers

January 14, 2011

New Cancer Education Grant Program Guidelines, Developed

February 6, 1987

Gene Expression Test Accurately Classifies “Inconclusive” Samples

July 27, 2012

Obituary: Gregory Foltz, Swedish Medical Center Neurosurgeon

July 12, 2013